Physician profile
Bryan T Kendricks
NPI 1477087898
$3,678.23
in general payments reported to CMS, 2019-2025
14 companies · $91.21 in 2025
The $91.21 reported for 2025 was less than what a typical Oral & Maxillofacial Surgery provider received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $772 · 2020: $326 · 2021: $1,276 · 2022: $365 · 2023: $556 · 2024: $293 · 2025: $91.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $811 · Gift: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.84 |
| Gift | $129.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $1,486.17 | 2019-2023 | Trumatch, Matrixorthognathic, Matrixmandible |
| Medical Device Business Services, INC. | $624.99 | 2019-2021 | |
| Axogen | $463.62 | 2021-2023 | Avance Nerve Graft |
| Stryker Corporation | $382.45 | 2020-2022 | |
| Straumann USA LLC | $320.81 | 2024-2025 | |
| Keystone Dental INC. | $145.20 | 2021 | |
| Biohorizons Implant Systems INC. | $63.51 | 2024-2025 | Biohorizons, Biohorizons Dental Implants |
| Geistlich Pharma, North America, INC. | $45.30 | 2019 | |
| Acera Surgical, INC. | $39.09 | 2019 | |
| Kls-Martin L.P. | $30.94 | 2023 | |
| Zimmer Biomet Holdings, INC. | $22.41 | 2021 | |
| Medtronic USA, INC. | $19.54 | 2020 | |
| Checkpoint Surgical, INC | $17.65 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $16.55 | 2023 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Kendricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.